863377-22-4 Usage
General Description
3-(Morpholino)phenylboronic acid is a chemical compound that belongs to the class of boronic acids. It consists of a phenyl group attached to a boronic acid moiety, with a morpholine ring attached to the phenyl group. 3-(MORPHOLINO)PHENYLBORONIC ACID is mainly used as a reagent in organic synthesis, particularly in Suzuki-Miyaura cross-coupling reactions to form carbon-carbon bonds. It has also been studied for its potential as a therapeutic agent in the treatment of cancer and other diseases. Additionally, 3-(Morpholino)phenylboronic acid has shown promising results in the development of fluorescent sensors for detecting carbohydrates and other biomolecules.
Check Digit Verification of cas no
The CAS Registry Mumber 863377-22-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,6,3,3,7 and 7 respectively; the second part has 2 digits, 2 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 863377-22:
(8*8)+(7*6)+(6*3)+(5*3)+(4*7)+(3*7)+(2*2)+(1*2)=194
194 % 10 = 4
So 863377-22-4 is a valid CAS Registry Number.
InChI:InChI=1/C10H14BNO3/c13-11(14)9-2-1-3-10(8-9)12-4-6-15-7-5-12/h1-3,8,13-14H,4-7H2
863377-22-4Relevant articles and documents
COMPOUNDS
-
Page/Page column 26, (2011/12/04)
A compound of formula (I) or a pharmaceutically acceptable salt or prodrug thereof: wherein R1 is CN; R2 is H or F; R3 and R4 are independently hydrogen, fluorine, chlorine or OR5; R5 is hydrogen, C1-6 alkyl, C1-6 alkenyl or C1-6 alkynyl; R6 and R7 are independently hydrogen, halogen, OR8 or NR9R10; R8 is hydrogen or C1-6 alkyl; R9 and R10 are independently hydrogen or C1-6 alkyl; or the groups R9 and R10 when they are attached to a nitrogen atom may together form a 5- or 6-membered ring which optionally contains one further heteroatom selected from NR8, S and O said 5 or 6 membered ring being optionally substituted by hydroxyl or C1-6 alkoxy; or the groups R9 and R10 when they are attached to a nitrogen atom may together form an azetidinyl ring optionally substituted by hydroxyl or C1-6 alkoxy, is provided. The use of such compounds in treating amyloid-related disease is also disclosed.
